Viveve Medical, Inc.
VIVE
|
$0.0003
59900.0%
150
|
Health Technology
(0.0% 1d) (0.0% 1m) (-99.6% 1y) (0.0% 2d) (0.0% 3d) (-33.3% 7d) (-77.84% volume)
Earnings Calendar: 2023-03-16
Market Cap: $ 3,217
http://www.viveve.com
Sec Filling | Patents | 55 employees
Viveve Medical, Inc. is a medical technology company focused on women's intimate health. It designs, develops, manufactures and markets a platform medical technology which refers to as Viveve system. The Viveve System consists of three main components: radiofrequency Generator, which produces a six-megahertz signal and is simple and efficient to operate; Handpiece, which holds the treatment tip in place and processes information about temperature, contact, cooling system function and other important data; Treatment Tip, which contains a proprietary internal EEPROM or Electrically Erasable Programmable Read-Only Memory chip, which stores treatment parameters and safety limits in order to optimize performance and safety. The company was founded on March 3, 1987 and is headquartered Englewood, CO.
optical women chip treatment eletrical
add to watch list Paper trade email alert is off
Press-releases
Crown Aesthetics Expands Further into the Asia Pacific Region
Published: 2023-06-05 (Crawled : 11:00) - prnewswire.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
| Email alert
Add to watchlist
asia
Delisting of Securities of Schmitt Industries, Inc.; Viveve Medical, Inc.; and American Virtual Cloud Technologies, Inc. from The Nasdaq Stock Market
Published: 2023-01-23 (Crawled : 22:00) - globenewswire.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 12.83%
H: 9.8%
C: -5.88%
SMIT | $0.0313 26.45% 4.5K
|
Producer Manufacturing
|
| O: 0.0%
H: 1.87%
C: 1.87%
NDAQ | $61.51 0.69% 0.68% 2.8M
|
Finance
|
| O: 0.16%
H: 0.14%
C: -0.8%
market cloud
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
Published: 2023-01-17 (Crawled : 12:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: -68.41%
H: 3.05%
C: -4.31%
topline trial
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
Published: 2022-12-15 (Crawled : 14:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 5.25%
H: 6.89%
C: 6.89%
trial
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Published: 2022-12-01 (Crawled : 14:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 2.41%
C: -0.21%
patent
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 22:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 6.67%
H: 0.0%
C: -10.54%
financial update results
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
Published: 2022-10-27 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.25%
report financial update results
Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Published: 2022-10-04 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 4.5%
C: -3.41%
patent
Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout
Published: 2022-09-27 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: 5.22%
H: 1.22%
C: -2.94%
treatment trial readout
Viveve to Participate in Ladenburg Thalmann Healthcare Conference
Published: 2022-09-22 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0003 59900.0% 150
|
Health Technology
|
| O: -0.25%
H: 1.3%
C: -5.19%
conference
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10